---
title: "JOHNSON PAUL D — Ownership Dossier"
canonical: https://whiteintel.dev/entity/53e9ebf2-9313-5b2a-9c21-e3f2e8246f4d
json: https://whiteintel.dev/api/public/dossier/53e9ebf2-9313-5b2a-9c21-e3f2e8246f4d
identifier: sec:0001891761
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# JOHNSON PAUL D

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001891761`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/53e9ebf2-9313-5b2a-9c21-e3f2e8246f4d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/53e9ebf2-9313-5b2a-9c21-e3f2e8246f4d  

## Ownership & control

### Holdings / subsidiaries

- **ATLAS THERAPEUTICS CORP** (director) — https://whiteintel.dev/entity/8b97634b-5e9b-5269-9883-c5d74eb16490
- **23andMe Holding Co.** (officer) — https://whiteintel.dev/entity/252e0929-8b97-5dc5-badb-c6b512928f0d

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **JOHNSON PAUL D**. Human view: https://whiteintel.dev/entity/53e9ebf2-9313-5b2a-9c21-e3f2e8246f4d · Structured JSON: https://whiteintel.dev/api/public/dossier/53e9ebf2-9313-5b2a-9c21-e3f2e8246f4d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._